EcoDrugPlus

Ensembl ID : ENSATEG00000014068
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSATEG00000013897
Gene Symbol: -
1 Cross references
196 Possible Orthologues:

Ensembl ID : ENSATEG00000002719
Gene Symbol: -
Cross references: -
390 Possible Orthologues:

Ensembl ID : ENSATEG00000012423
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSATEG00000002762
Gene Symbol: -
Cross references: -
390 Possible Orthologues:

Ensembl ID : ENSATEG00000012022
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSATEG00000012015
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSATEG00000003395
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSATEG00000011569
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSATEG00000020885
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSATEG00000003411
Gene Symbol: -
Cross references: -
373 Possible Orthologues:

Ensembl ID : ENSATEG00000001985
Gene Symbol: -
Cross references: -
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).